Your trusted source for investing success

Tag: united states

Battery Metals in 2018


Click to download your free report


Nemaska Lithium Launches a USD 300-350M Bond Offering

Nemaska Lithium Launches a USD 300-350M Bond Offering

Nemaska Lithium Inc. (TSX:NMX,OTCQX:NMKEF) (“Nemaska Lithium” or the “Corporation”) is pleased to announce that it is launching an offering of senior secured callable bonds (“Bonds”) on a private placement basis for proceeds of USD 300-350M (the “Bond Offering”).

Azarga Uranium Executes Replacement Earn-in Agreement for Kyzyl Ompul Project

Azarga Uranium Executes Replacement Earn-in Agreement for Kyzyl Ompul Project

AZARGA URANIUM CORP. (TSX:AZZ) (“Azarga Uranium” or the “Company”) is pleased to announce that its 70% controlled subsidiary, UrAsia in Kyrgyzstan Limited Liability Company (“UrAsia”), has executed a replacement earn-in agreement (the “Agreement”) with Central Asian Uranium Company Limited Liability Corporation (“Central”), whose representatives were a party to the earn-in

Graphite Mining in the US

Graphite Mining in the US

The US currently produces no graphite, and many are wondering if graphite mining in the US will happen. Here’s an overview of the situation.

RISE Life Science Corp. Announces Closing $2.2M of Equity Financing

RISE Life Science Corp. Announces Closing $2.2M of Equity Financing

RISE Life Science Corp. (CSE: RLSC) (formerly Luminor Medical Technologies Inc. (the “Company” or “RISE”) is pleased to announce that, further to it press release dated March 29, 2018, it has closed tranches (each a “Tranche”) of its previously announced non-brokered private placement (the “Offering”) through the issuance of an

Hemostemix Announces US FDA Clinical Trial Approval

Hemostemix (TSXV:HEM), a clinical-stage, autologous cell-therapy company, is pleased to announce that the United States Food and Drug Administration has raised no objections to the Company’s Investigational New Drug application.  This allows the Company to expand its Phase II clinical trial for critical limb ischemia to enroll patients at clinical sites

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
How We Got Here — 2018's Major Market Catalysts

URL: https://investingnews.com/daily/resource-investing/major-market-catalysts/